CN104546677A - Inosine composition freeze-drying tablet and preparation method thereof - Google Patents

Inosine composition freeze-drying tablet and preparation method thereof Download PDF

Info

Publication number
CN104546677A
CN104546677A CN201410829176.8A CN201410829176A CN104546677A CN 104546677 A CN104546677 A CN 104546677A CN 201410829176 A CN201410829176 A CN 201410829176A CN 104546677 A CN104546677 A CN 104546677A
Authority
CN
China
Prior art keywords
inosine
tablet
solution
hours
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410829176.8A
Other languages
Chinese (zh)
Inventor
李祖红
汪宁卿
李珠珠
饶经纬
李彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Original Assignee
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Weikang Pharmaceutical Qianshan Co Ltd filed Critical Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority to CN201410829176.8A priority Critical patent/CN104546677A/en
Publication of CN104546677A publication Critical patent/CN104546677A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides an inosine composition freeze-drying tablet and a preparation method thereof, and relates to the technical field of medicines and medicine production. The inosine composition freeze-drying tablet comprises inosine, starch and cane sugar, wherein starch and cane sugar are adopted as auxiliary materials. As ordinary corn starch is subjected to heating process treatment, the adhesion and disintegration functions of starch in the tablet are improved, the formability of the tablet is improved, and the inosine composition freeze-drying tablet only needs two auxiliary materials, that is, starch and cane sugar. The inosine composition freeze-drying tablet is prepared by using a freeze-drying process that the temperature is reduced twice and increased twice, so that the formability of the tablet is relatively good, the dissolution rate of the tablet is increased, and the bioavailability of the tablet is improved; defects of ordinary inosine tablets are overcome, the types and use amount of auxiliary materials in the inosine tablet are reduced, the tablet is high in dissolution rate and high in bioavailability, and the curative effect and the security of the tablet in clinical medication are ensured.

Description

A kind of inosine in combination thing lyophilizing sheet and preparation method thereof
Technical field
The present invention relates to medicine and medical production technical field, be specifically related to a kind of inosine in combination thing lyophilizing sheet and preparation method thereof.
Background technology
Inosine is the ingredient of ATP in body, coenzyme A, ribonucleic acid and DNA (deoxyribonucleic acid), participates in substance metabolism and the energy metabolism of body.It can improve the level of body ATP, can be converted into multiple nucleotide, and participates in the synthesis of protein.
Molecular weight: 268.23
In common Inosine tablets containing supplementary product kind and quantity more, generally to use filler, lubricant, disintegrating agent, adhesive, correctives etc., according to Chinese Pharmacopoeia (2010 editions) second quality of inosine tablets standard, the dissolution of Inosine tablets reached more than 80% for qualified 30 minutes time, and increasing research shows that impurity in the incompatibility of the toxic and side effects of adjuvant itself, adjuvant and principal agent, adjuvant etc. all can have an impact to the safety of medicine.
Therefore, provide one can overcome above-mentioned shortcoming, select suitable adjuvant and technique, reduce supplementary product kind and consumption in Inosine tablets, improve dissolution and the bioavailability of Inosine tablets, ensure that the safety of clinical application all has positive effect.
Traditional lyophilizing tablet can improve dissolution and bioavailability, but still need use the adjuvant such as mannitol, gelatin.And mannitol has certain biological activity, gelatin resource-constrained and perishable.
Starch is the basic adjuvant of oral solid formulation, it is polymerized by glucose molecule, and be commonly used for adhesive, diluent and disintegrating agent in tablets, it is cheap and easy to get, to human-body safety, but being used alone starch has no report as adjuvant freeze-dry process production inosine lyophilizing sheet.
Summary of the invention
Technical problem to be solved by this invention is the defect overcoming prior art, and propose a kind of inosine in combination thing lyophilizing sheet and preparation method thereof further, said preparation adjuvant is few, good stability, and bioavailability is high.
Technical problem to be solved by this invention realizes by the following technical solutions:
A kind of inosine in combination thing lyophilizing sheet, does adjuvant with starch and sucrose, produces with freeze-dry process, this tablet overcomes the shortcoming of above-mentioned common Inosine tablets, decreases supplementary product kind and consumption in Inosine tablets, and this sheet dissolution is large, bioavailability is high, ensure that curative effect and the safety of clinical application.
A kind of inosine in combination thing lyophilizing sheet, is prepared from by following raw material:
A preparation method for inosine in combination thing lyophilizing sheet, comprises step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take inosine 200 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring Inosine Content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain inosine in combination thing lyophilizing sheet.
Described starch selects corn starch, preferably the corn starch solution of 10% (W/V).
Beneficial effect of the present invention is:
The preparation method of a kind of inosine in combination thing lyophilizing sheet of the present invention, heating process process is carried out to common corn starch, starch bonding in tablets, disintegration can be improved, improve the mouldability of tablet, in inosine in combination thing lyophilizing sheet, dosage of sucrose is 8.5% (W/V), it is the hardness reinforcer of this tablet, and plays flavored action.Inosine in combination thing lyophilizing sheet only needs starch and sucrose two kinds of adjuvants.The freeze-dry process of two liters falls in inosine in combination thing lyophilizing sheet employing two, and twice cooling, twice intensification can make sheet mouldability better, which increase the dissolution of tablet, thus improve the bioavailability of tablet.
Accompanying drawing explanation
Fig. 1 is the dissolution correlation curve figure of inosine in experiment.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, set forth the present invention further, but following embodiment being only the preferred embodiments of the present invention, and not all.Based on the embodiment in embodiment, those skilled in the art under the prerequisite not making creative work obtain other embodiment, all belong to the protection domain of this patent.
Embodiment 1
A, take the corn starch of 100g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 9% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take inosine 200g, add in 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring Inosine Content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain inosine in combination thing lyophilizing sheet.
Embodiment 2
A, take the corn starch of 130g, the purified water adding 900ml stirs, and controls at 5-7.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 13% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take inosine 200 grams (by 1000 calculations), add 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring Inosine Content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain inosine in combination thing lyophilizing sheet.
Experimental data
The inosine in combination thing lyophilizing sheet that above-described embodiment is obtained carries out following quality research test:
1, hardness, friability contrast test
Get inosine in combination thing lyophilizing sheet prepared by above-described embodiment respectively and inosine ordinary tablet (commercially available) detects friability and hardness by " Chinese Pharmacopoeia " version in 2010 two annex X G inspection techniques, carried out comparative study, the results are shown in following table:
Sample Hardness/N Friability
Execute example 1 66 <1%
Execute example 2 65 <1%
Ordinary tablet 69 <1%
Experimental data shows, inosine in combination thing lyophilizing sheet and ordinary tablet (commercially available) without significant difference, meet " Chinese Pharmacopoeia " version in 2010 to the requirement of tablet on friability and hardness.
2, dissolution contrast test
(No. 1 to No. 3 is embodiment 1 to get Inosine tablets (commercially available) and each 6 of inosine in combination thing lyophilizing sheet, No. 4 to No. 6 is embodiment 2), press Chinese Pharmacopoeia (2010 editions) second dissolution method annex X C second method respectively, with water 900mL for dissolution medium, rotating speed is 75 turns per minute, operate in accordance with the law, respectively through 5min, 10min, 20min, 30min, during 60min, get solution 10ml, filter, precision measures continuous worry liquid 5ml, put in 100ml measuring bottle, be diluted with water to scale, shake up, according to Chinese Pharmacopoeia (2010 editions) second annex IV A ultraviolet visible spectrophotometry, absorbance is measured at the wavelength place of 248nm, separately get inosine reference substance appropriate, accurately weighed, be dissolved in water and quantitatively dilute the solution made containing 10 μ g in every 1ml, be measured in the same method, calculate the stripping quantity of every sheet, result is as follows:
One, Inosine tablets (commercially available)
Two, inosine lyophilizing sheet (No. 1 to No. 3 is embodiment 1, and No. 4 to No. 6 is embodiment 2)
Respectively with catch cropping Dissolution profiles during average dissolution pair, as Fig. 1.
Four, result judges
Judge according to Chinese Pharmacopoeia (2010 editions) second quality of inosine tablets standard, the dissolution of Inosine tablets (commercially available) reached more than 80% for qualified 30 minutes time, actual measurement is 81.4%, and inosine lyophilizing sheet dissolution 20 minutes time reaches 81.45%.It can thus be appreciated that the time that inosine lyophilizing sheet dissolution reaches 80% decreased for about 33.3% (10 minutes) time than Inosine tablets (commercially available).So the inosine lyophilizing sheet blood drug level peaking time is shorter than Inosine tablets (commercially available), and bioavailability is higher, better efficacy.
More than show and describe ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.

Claims (2)

1. an inosine in combination thing lyophilizing sheet, is characterized in that, is prepared from by following raw material:
2. a preparation method for inosine in combination thing lyophilizing sheet according to claim 1, is characterized in that, comprise step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 5-7.5, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take inosine 200 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring Inosine Content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain inosine in combination thing lyophilizing sheet.
CN201410829176.8A 2014-12-25 2014-12-25 Inosine composition freeze-drying tablet and preparation method thereof Pending CN104546677A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410829176.8A CN104546677A (en) 2014-12-25 2014-12-25 Inosine composition freeze-drying tablet and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410829176.8A CN104546677A (en) 2014-12-25 2014-12-25 Inosine composition freeze-drying tablet and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104546677A true CN104546677A (en) 2015-04-29

Family

ID=53064463

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410829176.8A Pending CN104546677A (en) 2014-12-25 2014-12-25 Inosine composition freeze-drying tablet and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104546677A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use
CN1491664A (en) * 2003-08-22 2004-04-28 洋浦华海医药物资有限公司 Composite medicinal preparation containing inosine matters

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use
CN1491664A (en) * 2003-08-22 2004-04-28 洋浦华海医药物资有限公司 Composite medicinal preparation containing inosine matters

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘晓睿: "《口腔速溶片的研究进展》", 《中南药学》 *

Similar Documents

Publication Publication Date Title
CN104490750A (en) Spirolactone composition freeze-dried tablets and preparation method thereof
CN104546766A (en) Mercaptopurine composition freeze-drying tablet and preparation method thereof
CN104490759A (en) Cobamamide composition freeze-dried tablets and preparation method thereof
CN104523629A (en) Lisinopril composition freeze-dried tablets and preparation method thereof
CN104490753A (en) Furosemide composition freeze-dried tablet and preparation method thereof
CN104586793A (en) Diazepam composition freeze-dried tablet and preparation method thereof
CN104546675A (en) Estazolam composition freeze-dried tablet and preparation method thereof
CN104546677A (en) Inosine composition freeze-drying tablet and preparation method thereof
CN104586749A (en) Metronidazole composition freeze-dried tablet and preparation method thereof
CN104490751A (en) Hydrochlorothiazide composition freeze-dried tablets and preparation method thereof
CN104546683A (en) Carbocisteine composition freeze-drying tablet and preparation method thereof
CN104546676A (en) Cimetidine composition freeze-drying tablet and preparation method thereof
CN104490830A (en) Bezafibrate composition freeze-dried tablet and preparation method thereof
CN104523614A (en) Vitamin B6 composition freeze-dried tablet and preparation method thereof
CN104546681A (en) Tinidazole composition freeze-dried tablet and preparation method thereof
CN104490758A (en) Leflunomide composition freeze-dried tablets and preparation method thereof
CN104546751A (en) Albendazole composition freeze-dried tablet and preparation method thereof
CN104606153A (en) Lyophilized perphenazine composition tablet and preparation method thereof
CN104434776A (en) Meloxicam composition lyophilized tablet and preparation method thereof
CN104523568A (en) Gliquidone composition freeze-dried tablet and preparation method thereof
CN104586790A (en) Methotrexate composition freeze-dried tablet and preparation method thereof
CN104546752A (en) Dipyridamole composition freeze-drying tablet and preparation method thereof
CN104606157A (en) Isoniazide composition lyophilized tablet and preparation method thereof
CN104586782A (en) Praziquantel composition freeze-dried tablet and preparation method thereof
CN104434831A (en) Glipizide composition freeze-dried tablet and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150429